Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Belimumab Hits Newer Remission, Low Disease Activity Metrics
TOPLINE: A greater proportion of patients with active systemic lupus erythematosus (SLE) treated with belimumab plus standard therapy achieved the newest definitions for remission and low disease activity compared with those treated with placebo plus standard therapy, with benefits observed…
English